Stock 300199 HYBIO PHARMACEUTICAL CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Company Hybio Pharmaceutical Co., Ltd.

Equities

300199

CNE1000011T7

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 06:00:00 2024-04-24 pm EDT 		5-day change 1st Jan Change
12.94 CNY +3.60% Intraday chart for Hybio Pharmaceutical Co., Ltd. +15.43% -4.71%
12:25pm Production Line of Hybio Pharma's Unit Passes Australian Regulator's Inspection MT
Apr. 18 Hybio Pharmaceutical Gets Regulatory Nod to Test Weight Management Injection; Shares Up 5% MT

Business Summary

Hybio Pharmaceutical Co., Ltd. is a China-based company principally involved in the development, manufacture and distribution of chemical synthetic polypeptide pharmaceuticals. The Company’s products include polypeptide preparations, polypeptide active pharmaceutical ingredients (APIs) and customer polypeptide, among which the preparation products include thymopentin for injection, somatostatin for injection, desmopressin for injection and terlipressin for injection, among others. Through its subsidiaries, the Company's newly added products are pharmaceutical packaging products, medical devices and solid products. The Company is also engaged in provision of related technological services.

Number of employees: 975

Sales per Business

CNY in Million2021Weight2022Weight Delta
Preparation
81.7 %
608 82.6 % 575 81.7 % -5.33%
Active Pharmaceutical Ingredient
12.7 %
56 7.6 % 90 12.7 % +59.36%
Solid
3.2 %
58 7.9 % 22 3.2 % -61.80%
Other
1.7 %
5 0.7 % 12 1.7 % +138.55%
Client Peptide
0.4 %
6 0.8 % 3 0.4 % -50.95%
Equipment
0.2 %
1 0.2 % 1 0.2 % -4.97%
Cosmetics
0.1 %
1 0.2 % 1 0.1 % -34.41%

Sales per region

CNY in Million2021Weight2022Weight Delta
China
88.7 %
689 93.6 % 625 88.7 % -9.28%
Foreign
11.3 %
47 6.4 % 79 11.3 % +68.86%

Managers

Managers TitleAgeSince
Yu Pin Xiang CEO
 Chief Executive Officer 51 19-05-30
Hong Hong Tu DFI
 Director of Finance/CFO 48 21-07-07
Yang Ming Tang BRD
 Director/Board Member 46 21-01-28
Di Yang BRD
 Director/Board Member - 20-04-05
Ping Ping Li IRC
 Investor Relations Contact - 22-01-24

Members of the board

Members of the board TitleAgeSince
Lian Zhong BRD
 Director/Board Member 63 21-08-22
Shao Gui Zeng CHM
 Chairman 56 09-10-26
Shao Qiang Zeng BRD
 Director/Board Member 53 09-10-26
Shao Bin Zeng BRD
 Director/Board Member 47 20-01-14
Wen Yan Hu BRD
 Director/Board Member 54 21-11-29
Yu Pin Xiang CEO
 Chief Executive Officer 51 19-05-30
Di Yang BRD
 Director/Board Member - 20-04-05
Qing Yang Li CHM
 Chairman 48 20-03-03
Lu Yang BRD
 Director/Board Member 42 21-08-21
Lin Liang BRD
 Director/Board Member 47 21-11-29

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 883,241,336 428,902,000 ( 48.56 %) 0 48.56 %

Shareholders

NameEquities%Valuation
Xiu Lan Li
6.631 %
44,161,966 6.631 % 74 M ¥
Shao Gui Zeng
1.812 %
12,069,218 1.812 % 20 M ¥
Shao Qiang Zeng
1.334 %
8,882,758 1.334 % 15 M ¥
Shao Bin Zeng
0.8152 %
5,429,255 0.8152 % 9 M ¥
Jian Ji Ma
0.6353 %
4,231,000 0.6353 % 7 M ¥
China Asset Management Co., Ltd.
0.6208 %
4,134,653 0.6208 % 7 M ¥
Jun Bin Liu
0.5171 %
3,444,100 0.5171 % 6 M ¥
Tian Xu Zhang
0.4483 %
2,985,753 0.4483 % 5 M ¥
Li Yun Hu
0.4299 %
2,863,400 0.4299 % 5 M ¥
Guotai Asset Management Co., Ltd.
0.0300 %
200,000 0.0300 % 336 772 ¥
NameEquities%Valuation
Shao Gui Zeng
44.92 %
97,568,542 44.92 % 164 M ¥
Shao Qiang Zeng
29.05 %
63,101,905 29.05 % 106 M ¥
Shao Bin Zeng
7.499 %
16,287,763 7.499 % 27 M ¥

Company contact information

Hybio Pharmaceutical Co.. Ltd.

Hanyu Innovation Industry Building No. 7 Guansheng 4th Road

518057, Shenzhen

+

http://www.hybio.com.cn
address Hybio Pharmaceutical Co., Ltd.(300199)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Generic Pharmaceuticals

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

1st Jan change Capi.
HYBIO PHARMACEUTICAL CO., LTD. Stock Hybio Pharmaceutical Co., Ltd.
-8.03% 1.52B
SUN PHARMACEUTICAL INDUSTRIES LTD. Stock Sun Pharmaceutical Industries Ltd.
+20.70% 42.78B
OTSUKA HOLDINGS CO., LTD. Stock Otsuka Holdings Co., Ltd.
+18.59% 22.25B
SANDOZ GROUP AG Stock Sandoz Group AG
+14.75% 14.39B
CIPLA LIMITED Stock Cipla Limited
+12.83% 13.55B
ZYDUS LIFESCIENCES LIMITED Stock Zydus Lifesciences Limited
+38.02% 11.27B
ONO PHARMACEUTICAL CO., LTD. Stock Ono Pharmaceutical Co., Ltd.
-9.80% 6.95B
THE MEDICINES COMPANY Stock The Medicines Company
-0.05% 6.79B
STADA ARZNEIMITTEL Stock STADA Arzneimittel
-8.87% 5.73B
ASPEN PHARMACARE HOLDINGS LIMITED Stock Aspen Pharmacare Holdings Limited
+6.29% 5.01B
Generic Pharmaceuticals
  1. Stock Market
  2. Equities
  3. 300199 Stock
  4. Company Hybio Pharmaceutical Co., Ltd.